ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.9571C>G (p.Gln3191Glu)

gnomAD frequency: 0.00007  dbSNP: rs33997263
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040929 SCV000064620 uncertain significance not specified 2012-10-17 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The Gln3191Glu vari ant in TTN has not been reported in the literature nor previously identified by our laboratory. It has been identified in 1/94 Han Chinese chromosomes from a b road population by the 1000 Genomes project (dbSNP rs33997263). Computational a nalyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Lys32641Gln variant may not impact the protein and se veral other species (including rat, birds, amphibians, and fish) carry a glutami c acid (Glu; this variant) despite high amino acid conservation nearby, suggesti ng that this variant may be tolerated, though this information is not predictive enough to rule out pathogenicity. This variant is more likely benign but at thi s time, additional information is needed to fully assess its clinical significan ce.
GeneDx RCV000040929 SCV000238063 uncertain significance not specified 2014-07-08 criteria provided, single submitter clinical testing Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in CARDIOMYOPATHY panel(s).
Ambry Genetics RCV000245580 SCV000319090 uncertain significance Cardiovascular phenotype 2013-09-20 criteria provided, single submitter clinical testing The p.Q3191E variant (also known as c.9571C>G) is located in coding exon 40 of the TTN gene. This alteration results from a C to G substitution at nucleotide position 9571. The glutamine at codon 3191 is replaced by glutamic acid, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs33997263. Based on data from the 1000 Genomes Project, the G-allele has an overall frequency of approximately 0.05% (1/2184). The highest observed frequency was 0.52% (1/194) Han Chinese chromosomes studied. This amino acid position is poorly conserved on sequence alignment. This variant is predicted to be benign by PolyPhen in silico analyses. Since supporting evidence is limited at this time, the clinical significance of p.Q3191E remains unclear.
Invitae RCV000643340 SCV000765027 uncertain significance Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2017-11-12 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002496653 SCV002784299 uncertain significance Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 2021-08-25 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.